NCT04166253View on ClinicalTrials.gov

Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

May 1, 2020

Conditions
Breast Cancer
Interventions
DRUG

Vitamin D

Alfacalcidol oral tablets once daily

Trial Locations (1)

22511

Damnhour university, Beheira

All Listed Sponsors
lead

Damanhour University

OTHER

NCT04166253 - Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin | Biotech Hunter | Biotech Hunter